AR070007A1 - NAFTALENIC DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - Google Patents
NAFTALENIC DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEMInfo
- Publication number
- AR070007A1 AR070007A1 ARP080102858A ARP080102858A AR070007A1 AR 070007 A1 AR070007 A1 AR 070007A1 AR P080102858 A ARP080102858 A AR P080102858A AR P080102858 A ARP080102858 A AR P080102858A AR 070007 A1 AR070007 A1 AR 070007A1
- Authority
- AR
- Argentina
- Prior art keywords
- branched
- linear
- disorders
- aryl
- alkyl
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 3
- 125000001072 heteroaryl group Chemical group 0.000 abstract 3
- 208000024827 Alzheimer disease Diseases 0.000 abstract 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 125000001188 haloalkyl group Chemical group 0.000 abstract 2
- 206010022437 insomnia Diseases 0.000 abstract 2
- 230000007170 pathology Effects 0.000 abstract 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 208000000044 Amnesia Diseases 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 208000027559 Appetite disease Diseases 0.000 abstract 1
- 208000019454 Feeding and Eating disease Diseases 0.000 abstract 1
- 208000026139 Memory disease Diseases 0.000 abstract 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 206010033664 Panic attack Diseases 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- 206010039966 Senile dementia Diseases 0.000 abstract 1
- 201000001880 Sexual dysfunction Diseases 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000032683 aging Effects 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000006267 biphenyl group Chemical group 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003433 contraceptive agent Substances 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 210000002249 digestive system Anatomy 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002526 effect on cardiovascular system Effects 0.000 abstract 1
- 206010015037 epilepsy Diseases 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000004446 heteroarylalkyl group Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- -1 hydroxy, carboxy, formyl Chemical group 0.000 abstract 1
- 239000002955 immunomodulating agent Substances 0.000 abstract 1
- 229940121354 immunomodulator Drugs 0.000 abstract 1
- 208000024714 major depressive disease Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000006984 memory degeneration Effects 0.000 abstract 1
- 208000023060 memory loss Diseases 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- 125000002950 monocyclic group Chemical group 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 208000019906 panic disease Diseases 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
- 208000012672 seasonal affective disease Diseases 0.000 abstract 1
- 231100000872 sexual dysfunction Toxicity 0.000 abstract 1
- 208000019116 sleep disease Diseases 0.000 abstract 1
- 230000035882 stress Effects 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Reivindicacion 1: Compuestos de formula (1): en la que R1 representa un grupo alquilo C1-6 lineal o ramificado, alquenilo C1-6 lineal o ramificado, halogenoalquilo C1-6 lineal o ramificado, polihalogenoalquilo C1-6 lineal o ramificado, cicloalquilo C3-8, cicloalquil C3-8 alquilo C1-6 cuya parte alquilo puede ser lineal o ramificada, arilo, arilalquilo C1-6 cuya parte alquilo puede ser lineal o ramificada, heteroarilo o heteroarilalquilo C1-6 cuya parte alquilo puede ser lineal o ramificada, R2 y R3, idénticos o diferentes, representan cada uno un átomo de hidrogeno o un grupo alquilo C1-6 lineal o ramificado, entendiéndose que: por arilo, se entiende un grupo fenilo, naftilo o bifenilo, por ôheteroariloö, se entiende cualquier grupo aromático mono o bicíclico que contiene 1 a 3 heteroátomos elegidos entre oxígeno, azufre y nitrogeno, pudiendo estar los grupos arilo y heteroarilo así definidos sustituidos con 1 a 3 grupos elegidos entre alquilo C1-6 lineal o ramificado, alcoxi C1-6 lineal o ramificado, hidroxi, carboxi, formilo, nitro, ciano, halogenoalquilo C1-6 lineal o. ramificado, polihalogenoalquilo C1-6 lineal o ramificado, alquiloxicarbonilo o átomos de halogeno, sus enantiomeros y diastereoisomeros, así como sus sales de adicion a un ácido o a una base aceptable farmacéuticamente. Reivindicacion 12: Composiciones farmacéuticas segun la reivindicacion 10 utiles para la fabricacion de medicamentos para el tratamiento de trastornos del sueno, estrés, ansiedad, depresion mayor o depresiones estacionales, patologías cardiovasculares, patologías del sistema digestivo, insomnios y fatigas debidos a diferencias horarias, esquizofrenia, ataques de pánico, melancolía, trastornos del apetito, obesidad, insomnio, trastornos psicoticos, epilepsia, diabetes, enfermedad de Parkinson, demencia senil, diversos trastornos asociados al envejecimiento normal o patologico, migrana, pérdidas de memoria, enfermedad de Alzheimer, trastornos de la circulacion cerebral, así como en las disfunciones sexuales, como inhibidores de la ovulacion, inmunomoduladores y en el tratamiento de los cánceres.Claim 1: Compounds of formula (1): wherein R1 represents a linear or branched C1-6 alkyl group, linear or branched C1-6 alkenyl, linear or branched C1-6 halogenoalkyl, linear or branched C1-6 polyhalogenoalkyl, cycloalkyl C3-8, C3-8 cycloalkyl C1-6 alkyl whose alkyl part can be linear or branched, aryl, C1-6 arylalkyl whose alkyl part can be linear or branched, heteroaryl or C1-6 heteroarylalkyl whose alkyl part can be linear or branched , R2 and R3, identical or different, each represent a hydrogen atom or a linear or branched C1-6 alkyl group, it being understood that: by aryl, a phenyl, naphthyl or biphenyl group is understood as by "heteroaryl" means any group mono or bicyclic aromatic containing 1 to 3 heteroatoms chosen from oxygen, sulfur and nitrogen, the aryl and heteroaryl groups thus being substituted substituted with 1 to 3 groups selected from linear or branched C1-6 alkyl, alkoxy C1-6 linear or branched, hydroxy, carboxy, formyl, nitro, cyano, halogenalkyl C1-6 linear or. branched, linear or branched C1-6 polyhalogenoalkyl, alkyloxycarbonyl or halogen atoms, their enantiomers and diastereoisomers, as well as their addition salts to a pharmaceutically acceptable acid or base. Claim 12: Pharmaceutical compositions according to claim 10 useful for the manufacture of medicaments for the treatment of sleep disorders, stress, anxiety, major depression or seasonal depressions, cardiovascular pathologies, digestive system pathologies, insomnia and fatigue due to time differences, schizophrenia , panic attacks, melancholy, appetite disorders, obesity, insomnia, psychotic disorders, epilepsy, diabetes, Parkinson's disease, senile dementia, various disorders associated with normal or pathological aging, migraine, memory loss, Alzheimer's disease, disorders of cerebral circulation, as well as in sexual dysfunctions, such as ovulation inhibitors, immunomodulators and in the treatment of cancers.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0704749A FR2918371B1 (en) | 2007-07-02 | 2007-07-02 | NOVEL NAPHTHALENIC DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR070007A1 true AR070007A1 (en) | 2010-03-10 |
Family
ID=38926389
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP080102858A AR070007A1 (en) | 2007-07-02 | 2008-07-02 | NAFTALENIC DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
Country Status (3)
| Country | Link |
|---|---|
| AR (1) | AR070007A1 (en) |
| FR (1) | FR2918371B1 (en) |
| WO (1) | WO2009022065A2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011097336A2 (en) * | 2010-02-04 | 2011-08-11 | The Board Of Trustees Of The University Of Illinois | Highly selective 5-ht(2c) receptor agonists having antagonist activity at the 5-ht(2b) receptor |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2713636B1 (en) * | 1993-12-07 | 1996-01-05 | Adir | New naphthalene derivatives, process for their preparation, and pharmaceutical compositions containing them. |
-
2007
- 2007-07-02 FR FR0704749A patent/FR2918371B1/en not_active Expired - Fee Related
-
2008
- 2008-07-01 WO PCT/FR2008/000934 patent/WO2009022065A2/en not_active Ceased
- 2008-07-02 AR ARP080102858A patent/AR070007A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009022065A2 (en) | 2009-02-19 |
| WO2009022065A3 (en) | 2009-04-16 |
| FR2918371A1 (en) | 2009-01-09 |
| FR2918371B1 (en) | 2009-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR059206A1 (en) | USE OF 4-IMIDAZOL DERIVATIVES FOR CNS DISORDERS | |
| AR047976A1 (en) | IMMUNOSUPPRESSOR COMPOUNDS AND COMPOSITIONS | |
| PE20091623A1 (en) | 1H-PYRAZOLO [3,4-b] PYRIDINE DERIVATIVES AS RAF KINASE INHIBITORS | |
| AR059016A4 (en) | DERIVATIVES OF ARIL-ISOXAZOL-4-IL-IMIDAZO [1,2-A] PIRIDINE, PREPARATION METHOD, MEDICINES CONTAINING THEM AND USES IN THE TREATMENT OF COGNITIVE DISORDERS. | |
| AR082667A1 (en) | 6-CICLOALQUIL-PIRAZOLOPIRIMIDINONAS FOR THE TREATMENT OF CNS DISORDERS | |
| AR066509A1 (en) | DERIVATIVES OF TIAZOL, DRUGS THAT CONTAIN THEM, PREPARATION PROCESS AND USES AS MODULATORS OF BETA AMYLOID. | |
| AR059895A1 (en) | BICYCLE DERIVATIVES OF CARBOXYLIC ACIDS THAT RESULT IN USEFULNESS TO TREAT METABOLIC DISORDERS | |
| AR070188A1 (en) | DERIVATIVES OF SUBSTITUTED SULFONAMIDS | |
| AR077975A1 (en) | PIRAZOL PYRIMIDINE DERIVATIVES AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS | |
| AR063327A1 (en) | AMINOMETIL-4-IMIDAZOLES. PROCESSES OF OBTAINING AND PHARMACEUTICAL COMPOSITIONS | |
| BRPI0612803A2 (en) | process for preparing a compound | |
| HRP20170095T1 (en) | New crystalline form iii of agomelatin, the process for its preparation and pharmaceutical compositions containing it | |
| AR061739A1 (en) | NEW NAFTALENIC DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| AR062209A1 (en) | MGLUR5 METABOTROPIC GLUTAMATE RECEPTORS MODULATING PIRAZOLOPIRIMIDINES, PROCESS FOR PREPARATION, MEDICATIONS CONTAINING THEM AND USES IN THE PREVENTION AND / OR TREATMENT OF ACUTE AND CHRONIC NEUROLOGICAL DISORDERS. | |
| AR083202A1 (en) | DERIVATIVES OF AZABICICLO [3.1.0] HEXANO | |
| AR087915A1 (en) | N- (3- (2-AMINO-6,6-DIFLUOR-4,4A, 5,6,7,7A-HEXAHYDRO-CYCLOPENTA- [E] [1,3] OXAZIN-4-IL) -PENYL) - AMIDAS AS INHIBITORS OF THE BACE1 | |
| ECSP13012896A (en) | AMINA HETEROCYCLIC DERIVATIVES | |
| AR072819A1 (en) | DERIVATIVES OF TRIAZOLO [4,3-A] PIRIDINE, PREPARATION PROCEDURE, INTERMEDIARIES OF SUCH PROCESS, PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND AND USE THE SAME, AS INHIBITORS OF MET PROTEINQUINASE, FOR THE TREATMENT OF CANCERESIST, PSCESESIS, PSC CENTRAL NERVOUS AND OTHER | |
| AR059207A1 (en) | USE OF 2-IMIDAZOL DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS | |
| AR089691A1 (en) | HETEROCICLIC DERIVATIVES | |
| MX2017001096A (en) | 2-oxa-5-azabicyclo[2.2.1]heptan-3-yl derivatives. | |
| ECSP099406A (en) | PROCESS FOR SYNTHESIS OF ACID DERIVATIVES 3-AMINO-TETRAHIDROFURAN-3-CARBOXÍLICO AND USE OF THE SAME AS MEDICATIONS | |
| AR050297A1 (en) | SUBSTITUTED HYDANTOINS | |
| AR070006A1 (en) | NAFTALENIC DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| AR065904A1 (en) | HETEROCICLES AS AN OREXINE ANTAGONISTS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |